U.S. Healthcare Services Stock News

Recent commentary on Aurora Innovation (AUR) has focused on its autonomous trucking progress, highlighting more than 250,000 fully driverless miles, plans for over 200 driverless trucks, and partnerships to support future hardware scaling and financial milestones. See our latest analysis for Aurora Innovation. Despite positive sentiment around its autonomous trucking milestones and the recent appointment of David Wehner to the board, Aurora Innovation’s 1 day, 7 day and 30 day share price...

Flotek Industries (FTK) has put up a busy FY 2025 so far, with Q3 revenue at US$56.0 million and basic EPS of US$0.57. This is backed by trailing 12 month revenue of US$220.5 million and basic EPS of US$0.99 that reflect the recent earnings ramp reported in the data. Looking back through the recent quarters, the company has seen revenue move from US$49.7 million in Q3 FY 2024 to US$56.0 million in Q3 FY 2025, while basic EPS shifted from US$0.09 to US$0.57 over the same period. This is framed...

Kansas City Life Insurance (KCLI) has wrapped up FY 2025 with fourth quarter revenue of US$120.4 million, basic EPS of US$0.23 and net income of US$2.3 million, alongside trailing 12 month revenue of US$485.5 million and a net loss of US$20.8 million, which translates to basic EPS of a US$2.14 loss. Over recent quarters the company has seen revenue move between US$118.98 million and US$125.15 million, while quarterly EPS has ranged from a US$2.90 loss to a US$0.33 profit. This sets up a story...

Inland Real Estate Income Trust (INRE) has posted its FY 2025 numbers with Q4 total revenue of US$38.7 million and a basic EPS loss of US$0.12, alongside funds from operations of US$36.3 million in the red. This gives investors a mixed read on operating performance and cash generation. Over the past year, total revenue has held in a tight band around US$150 million on a trailing twelve month basis while basic EPS for the same period came in at a loss of US$0.31, underscoring a sustained loss...

Mistras Group (MG) just closed out FY 2025 with fourth quarter revenue of US$181.5 million and basic EPS of US$0.12, alongside trailing twelve month revenue of US$724.0 million and EPS of US$0.54 that were shaped by a reported net profit margin of 2.3%. Over recent periods, the company has seen quarterly revenue move from US$172.7 million in FY 2024 Q4 to US$195.5 million in FY 2025 Q3 before landing at US$181.5 million in FY 2025 Q4. Quarterly EPS ranged from a loss of US$0.10 in FY 2025 Q1...

TechTarget (TTGT) has just posted its FY 2025 numbers with Q4 revenue of US$140.7 million and a basic EPS loss of US$0.13, capping a trailing 12 month period that featured revenue of US$486.8 million and a basic EPS loss of US$14.06. Over recent quarters, the company has seen revenue move from US$99.9 million in Q4 FY 2024 to US$103.9 million in Q1 FY 2025, US$119.9 million in Q2, US$122.3 million in Q3 and US$140.7 million in Q4. Quarterly basic EPS losses shifted from US$0.90 to US$7.32,...

Build A Bear Workshop (BBW) has just reported new figures for FY 2026, with third quarter revenue of US$122.7 million and basic EPS of US$0.62. Trailing twelve month figures show revenue of US$525.8 million and EPS of US$4.38 backed by net income of US$57.5 million. Over recent quarters the company has seen revenue move from US$119.4 million in Q3 2025 to US$150.4 million in Q4 2025 and then to US$128.4 million and US$124.2 million in Q1 and Q2 2026. Basic EPS was US$0.64, US$1.63, US$1.17...

In recent days, Tesla reported a sharp rebound in China-made Model 3 and Model Y sales from its Shanghai factory while also securing Ofgem approval for its Tesla Energy Ventures unit to sell electricity to homes and businesses across Britain. These developments highlight how Tesla’s growth is increasingly tied to international markets and its energy operations, even as it faces executive turnover and ongoing regulatory scrutiny of its Full Self-Driving technology. We’ll now examine how the...

PayPal Holdings (PYPL) is in the spotlight after weak Q4 and full year 2025 results, a sudden CEO ousting, and a wave of securities class action lawsuits focused on its core Branded Checkout growth messaging. See our latest analysis for PayPal Holdings. At a share price of US$44.36, the recent 1 day share price return of a 2.66% decline and 7 day share price return of a 6.88% decline sit against a 90 day share price return of a 28.06% decline and 1 year total shareholder return of a 33.35%...

Sealed Air (NYSE:SEE) has announced its intention to redeem multiple senior notes, subject to the closing of a pending transaction. The planned redemptions would retire certain outstanding debt instruments once the transaction is completed. The company has outlined the expected redemption terms ahead of closing to give bondholders and shareholders clarity on next steps. For investors watching Sealed Air, the focus now is on how this conditional redemption plan fits with the company’s...

ANI Pharmaceuticals, Inc. recently reported fourth-quarter 2025 sales of US$247.06 million, up from US$190.57 million a year earlier, and moved from a net loss to net income of US$27.49 million. Alongside reaffirmed 2026 revenue guidance of US$1.06 billion to US$1.12 billion, management highlighted rare disease therapies and Cortrophin Gel as central to the company’s growth plans. Now we'll examine how ANI Pharmaceuticals' reaffirmed 2026 revenue guidance and rare disease expansion shape the...

What ESCO Technologies investors are looking at today ESCO Technologies (ESE) trades around $266.43, with recent returns showing a 1 day decline of 1.6% and a 4.3% drop over the past month, following gains over the past 3 months and year. See our latest analysis for ESCO Technologies. Short term momentum has cooled, with a 1 month share price return of a 4.3% decline. However, the 1 year total shareholder return of 70.15% suggests longer term sentiment has remained strong, likely reflecting...

Aflac (NYSE:AFL) has entered into a new partnership with Empower Brokerage. The agreement authorizes more than 8,000 independent Empower agents to offer Aflac insurance products. The collaboration was recently announced and expands Aflac's distribution footprint across the independent agent channel. Aflac, known for its supplemental health and life insurance offerings, is leaning into distribution partnerships as the insurance sector adapts to changing customer expectations and sales...

The Marzetti Company recently introduced its new Marzetti Simply Dressed salad dressings line, featuring six flavors with simplified ingredient lists that will replace the prior Marzetti Simply products on grocery shelves nationwide. This shift toward a cleaner-label, flavor-focused range suggests Marzetti is actively aligning its core dressings portfolio with health-conscious consumer preferences and premium at-home eating trends. With this cleaner-label Simply Dressed relaunch, we’ll now...

If you are looking at Worthington Enterprises and wondering whether the current share price reflects its true value, this article will walk you through what the numbers are actually saying. The stock last closed at US$46.99, after a 7 day return of a 9.9% decline, a 30 day return of an 18.8% decline, a year to date return of a 9.6% decline, but a 1 year return of 18.8% and a 3 year return of 47.2% that sits ahead of its 5 year return of 16.3%. Recent coverage around Worthington Enterprises...

Merit Medical Systems Stock Moves After Recent Performance Shift Merit Medical Systems (MMSI) has drawn fresh attention after a stretch of weaker share performance, with the stock showing negative returns over the past week, month, past 3 months, and year to date. See our latest analysis for Merit Medical Systems. At a share price of US$68.17, Merit Medical Systems is coming off a sharp 21.37% 3 month share price decline and a 30.20% 1 year total shareholder return loss, although the 5 year...

If you are looking at EchoStar and wondering whether the current share price still offers value, this article will walk through what the numbers actually say rather than the headlines. EchoStar shares last closed at US$107.71, after a 2.8% decline over 7 days and a 6.9% decline over 30 days, set against a 308.1% return over 1 year and a 477.5% return over 3 years. These price moves sit against a backdrop of ongoing investor interest in the company and its position in the media and satellite...

Enphase Energy (ENPH) has been back in focus after its Q4 EPS of $0.71 topped expectations, aided by 21% sequential U.S. sell through growth and the U.S. launch of IQ9 Commercial Microinverters. See our latest analysis for Enphase Energy. At a share price of US$43.34, Enphase has had a mixed run, with a 31.29% 90 day share price return and a 28.41% year to date share price return, yet a 25.89% 1 year total shareholder return decline pointing to pressure over a longer stretch. If this story...

In February 2026, Travere Therapeutics reported past fourth quarter and full-year results showing strong U.S. net product sales growth driven by FILSPARI, while also flagging an expected US$25,000,000 sales-based milestone from Mirum Pharmaceuticals in the first half of 2026. This combination of robust FILSPARI performance and upcoming milestone income highlights how Travere’s rare kidney disease franchise is increasingly central to its revenue mix. With FILSPARI’s sales strength now...

In recent days, Carpenter Technology has drawn attention as technical analysts highlighted the stock moving above its 20-day moving average while analysts raised earnings estimates for the current fiscal year. An added angle is the scrutiny around Senator Markwayne Mullin’s recent share purchases in Carpenter Technology, given his role on the Senate Armed Services Committee and pending nomination to lead the Department of Homeland Security, which raises fresh questions about potential...

If you are wondering whether Axsome Therapeutics shares are still offering value at around US$159.50, it helps to step back and look at what the current price actually implies. The stock has seen mixed returns, with a 2.8% decline over the last 7 days and a 12.9% decline over the last 30 days, while still sitting on a 33.5% return over 1 year, 157.5% over 3 years, and 134.3% over 5 years. Recent attention on Axsome Therapeutics has focused on its pipeline progress and broader sentiment...

If you are wondering whether Arch Capital Group is attractively priced or already fully valued, you are not alone. This article is designed to help you make sense of where the current share price sits. The stock last closed at US$94.22, with returns of 0.4% year to date and 4.2% over the past year. The 3 year and 5 year returns sit at 50.0% and 163.3%, even after recent 7 day and 30 day declines of 2.9% and 3.7%. Recent coverage has focused on Arch Capital Group's position in the insurance...

If you are wondering whether Southwest Airlines at around US$41.85 is still offering value after a strong run, you are not alone. This article will help you frame that question clearly using several valuation tools. The stock is up 41.8% over the past year and 50.4% over three years, even though the last month saw a 21.6% decline and the last week a further 11.2% drop. These moves can change how the market is pricing its potential and risk. Recent headlines around Southwest have focused on...

In the third quarter, Victory Capital Management Inc. reduced its stake in Applied Industrial Technologies by 45.2%, cutting its holdings to 86,330 shares from 157,638 shares previously. This sizeable adjustment by a prominent institutional shareholder raises questions about how large investors currently view Applied Industrial Technologies’ positioning and prospects. We will now examine how Victory Capital’s substantial stake reduction might influence Applied Industrial Technologies’...